Health Sciences Acquisition Corporation (HSACU), announced the pricing of their $100 million SPAC IPO tonight and the units are expected to begin trading tomorrow, May 10th, under the symbol Nasdaq: HSACU.
Additionally, the underwriters have announced that they have fully exercised the over-allotment option to purchase an additional 1,500,000 units.
Health Sciences, which will be focusing on BioPharma and MedTech companies, will be led by Roderick Wong, MD, as President, CEO and Chairman, as well as senior members of RTW investments.
Total SPAC deal count for 2019 year-to-date is now 20 with $4.514 billion in gross proceeds raised. The offering is expected to close on or about May 14th, 2019.
Congratulations to all.
Chardan and UBS acted as joint book-running managers.
Loeb & Loeb LLP and Kirkland & Ellis LLP, were Issuer’s Counsel and Underwriter’s Counsel, respectively.